← Eichor
Study identifier: NCT07027475 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Acute Treatment and Long-term Assessment of Adult Infectious Meningitis

Condition: Viral Meningitis · Bacterial Meningitis · Fungal Meningitis  ·  Sponsor: Hospital Israelita Albert Einstein

PhaseN/A
Planned participants624
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Prospective, multicenter, observational clinical registry of adult patients with acute infectious meningitis across approximately 30 public and private hospitals in Brazil. The study will include adults, 18 years old and older, with suspected acute infectious meningitis. Data will be collected during hospitalization and post-discharge to evaluate clinical management, treatment and short and long-term outcomes. The study aims to generate real-world evidence on current practices and outcomes to support improvements in national care protocols.

This description comes directly from the study's public registry record.

Talk to the study team

Anna M Gomes, MD  ·  +55 11 2151-1233  ·  anna.gomes@einstein.br

Always discuss trial participation with your own doctor first.

Locations (3)

Hospital São Vicente de PauloPasso Fundo, Rio Grande do Sul, BrazilRecruiting
Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - USPRibeirão Preto, São Paulo, BrazilRecruiting
Hospital Santa MarcelinaSão Paulo, São Paulo, BrazilRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07027475